ethyl (E)-3-([1,1'-biphenyl]-4-yloxy)acrylate | 1155662-99-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl (E)-3-([1,1'-biphenyl]-4-yloxy)acrylate
• 英文别名: ethyl (E)-3-(biphenyl-4-yloxy)-acrylate；ethyl (E)-3-(4-phenylphenoxy)prop-2-enoate
• CAS: 1155662-99-9
• 化学式: C₁₇H₁₆O₃
• 分子量: 268.312
• InChiKey: SZOSEZRSIWIFFF-OUKQBFOZSA-N

物化性质

• 熔点：
  74-76 °C
• 沸点：
  390.2±35.0 °C(predicted)
• 密度：
  1.109±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl (E)-3-([1,1'-biphenyl]-4-yloxy)acrylate 在 lithium hydroxide monohydrate 、 水 、 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 24.0h， 以53%的产率得到(E)-3-(4-phenylphenoxy)prop-2-enoic acid
  参考文献：
  名称：

  Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors

  摘要：

  A series of hydroxamic acid-based histone deacetylase (HDAC) inhibitors were designed on the basis of a model of the HDAC2 binding site and synthesized. They are characterized by a cinnamic spacer, capped with a substituted phenyl group. Modifications of the spacer are also reported. In an in vitro assay with the isoenzyme HDAC2, a good correlation of the activity with the docking energy was found. In human ovarian carcinoma IGROV-1 cells, selected compounds produced significant acetylation of p53 and alpha-tubulin. Most compounds showed an antiproliferative activity comparable to that of SAHA. At equitoxic concentrations, the tested compounds were more effective than SAHA in inducing apoptotic cell death. Compounds selected for in vivo evaluation exhibited a significant antitumor activity on three tumor models at well tolerated doses, thus suggesting a good therapeutic index. (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.11.005
• 作为产物：
  描述：

  对羟基联苯 、 丙炔酸乙酯 在 N-甲基吗啉 作用下， 以 二氯甲烷 为溶剂， 反应 0.17h， 以81%的产率得到ethyl (E)-3-([1,1'-biphenyl]-4-yloxy)acrylate
  参考文献：
  名称：

  路易斯酸催化3-芳氧基丙烯酸酯的环状部分二聚为4-芳基苯并-2-酮：托特罗定，RORγ抑制剂和GPR40激动剂的类似物的合成†

  摘要：

  已经开发了由路易斯酸（BF 3 ·OEt 2）催化的3-芳氧基丙烯酸丙烯酸酯的诱人的环状二聚化为4-芳基苯并二氢吡喃酮。该反应涉及两分子的3-芳氧基丙烯酸酯，导致失去一个丙酸酯分子以提供4-芳基苯并二氢吡喃-2-酮，4-芳基苯并吡喃-2-酮是在许多天然产物中发现的重要结构基序。已详细阐述了该方法以合成托特罗定，RORγ抑制剂和GPR40激动剂的类似物。

  DOI：

  10.1039/c8cc09785b

文献信息

• Lewis acid-catalyzed annulative partial dimerization of 3-aryloxyacrylates to 4-arylchroman-2-ones: synthesis of analogues of tolterodine, RORγ inhibitors and a GPR40 agonist
  作者：Rupesh A. Kunkalkar、Rodney A. Fernandes

  DOI：10.1039/c8cc09785b

  日期：——

  annulative partial dimerization of 3-aryloxyacrylates to 4-arylchroman-2-ones catalyzed by Lewis acid (BF3·OEt2) has been developed. The reaction involves two molecules of 3-aryloxyacrylate, resulting in the loss of one propiolate molecule to furnish 4-arylchroman-2-one, an important structural motif found in many natural products. This methodology has been elaborated to synthesize analogues of tolterodine

  已经开发了由路易斯酸（BF 3 ·OEt 2）催化的3-芳氧基丙烯酸丙烯酸酯的诱人的环状二聚化为4-芳基苯并二氢吡喃酮。该反应涉及两分子的3-芳氧基丙烯酸酯，导致失去一个丙酸酯分子以提供4-芳基苯并二氢吡喃-2-酮，4-芳基苯并吡喃-2-酮是在许多天然产物中发现的重要结构基序。已详细阐述了该方法以合成托特罗定，RORγ抑制剂和GPR40激动剂的类似物。
• Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
  作者：Sabrina Dallavalle、Raffaella Cincinelli、Raffaella Nannei、Lucio Merlini、Gabriella Morini、Sergio Penco、Claudio Pisano、Loredana Vesci、Marcella Barbarino、Valentina Zuco

  DOI：10.1016/j.ejmech.2008.11.005

  日期：2009.5

  A series of hydroxamic acid-based histone deacetylase (HDAC) inhibitors were designed on the basis of a model of the HDAC2 binding site and synthesized. They are characterized by a cinnamic spacer, capped with a substituted phenyl group. Modifications of the spacer are also reported. In an in vitro assay with the isoenzyme HDAC2, a good correlation of the activity with the docking energy was found. In human ovarian carcinoma IGROV-1 cells, selected compounds produced significant acetylation of p53 and alpha-tubulin. Most compounds showed an antiproliferative activity comparable to that of SAHA. At equitoxic concentrations, the tested compounds were more effective than SAHA in inducing apoptotic cell death. Compounds selected for in vivo evaluation exhibited a significant antitumor activity on three tumor models at well tolerated doses, thus suggesting a good therapeutic index. (C) 2008 Elsevier Masson SAS. All rights reserved.